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The etiopathogenesis of primary sclerosing cholangitis is unknown. Genetic variants of fucosyltransferase 2 (FUT2) have been identified in genome-wide association studies as risk factors for primary sclerosing cholangitis. We investigated the role of Fut2 in murine liver pathophysiology by studying Fut2 -/-mice. Fut2 -/-mice were viable and fertile, had lower body weight than wild-type (wt) littermates and gray fur. Half of the Fut2 -/-mice showed serum bile salt levels 40 times higher than wt (Fut2 -/-high ), whereas the remainder were normocholanemic (Fut2 -/-low ). Fut2 -/-mice showed normal serum liver tests, bile flow, biliary bile salt secretion, fecal bile salt loss, and expression of major hepatocellular bile salt transporters and cytochrome P450 7a1, the key regulator of bile salt synthesis, indicating that elevated serum bile salts in Fut2 -/-high mice were not explained by cholestasis. Fut2 -/-high mice, but not Fut2 -/-low mice, were sensitive to hydrophobic bile salt feeding (0.3% glycochenodeoxycholate); they rapidly lost weight and showed elevation of serum liver tests (alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase) and areas of liver parenchymal necrosis. Histomorphological evaluation revealed the presence of paraportal shunting vessels, increased numbers of portal vascular structures, wall thickening of some portal arteries, and periductal fibrosis in Fut2 -/-high mice more than Fut2 -/-low mice and not wt mice.
Unconjugated bilirubin and ammonia were or tended to be elevated in Fut2 -/-high mice only. Portosystemic shunting was demonstrated by portal angiography, which disclosed virtually complete portosystemic shunting in Fut2 -/-high mice, discrete portosystemic shunting in Fut2 -/-low mice, and no shunting in wt littermates. Conclusion: Liver pathology in Fut2 -/-mice is dominated by consequences of portosystemic shunting resulting in microcirculatory disturbances, mild (secondary) periductal fibrosis, and sensitivity toward human bile salt toxicity. (HEPATOLOGY 2017;66:542-554).
P rimary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by a fibrosing cholangitis with strictures and dilatations along the biliary tree. PSC is in 60%-80% of patients associated with inflammatory bowel disease, mainly ulcerative colitis. Because the etiopathogenesis of PSC remains elusive to date, current treatment options are limited, and the disease slowly progresses to end-stage liver disease in the majority of patients, requiring liver transplantation.
(1) Besides complications of end-stage liver disease and secondary biliary infections, malignancies of the biliary tree and the colon determine long-term prognosis for the majority of PSC patients.
Genetic risk factors most likely contribute to disease development as first-degree relatives of PSC patients Abbreviations: ALT, alanine aminotransferase; ANOVA, two-way analysis of variance; AST, aspartate aminotransferase; Ck, cytokeratin; Cyp7a1, cytochrome P450 7a1; FUT2, fucosyltransferase 2; GCDC, glycochenodeoxycholate; GWAS, genome-wide association study; HPLC, high-performance liquid chromatography; Mdr, multidrug resistance; PSC, primary sclerosing cholangitis; SD, standard deviation; wt, wild type.
may have a nearly 100-fold increased risk to be affected by PSC in comparison to the general population. (2) Also, genome-wide association studies (GWAS) have disclosed a number of risk loci. The strongest genetic risk for PSC has been confirmed at the human leukocyte antigen locus (B), but also a number of nonhuman leukocyte antigen gene associations have been identified. (3) Among these, allelic variants responsible for the inactivation of fucosyltransferase 2 (FUT2), a known risk gene for Crohn's disease, have been shown to confer susceptibility for PSC development. (4) The enzyme FUT2 is responsible for the addition of fucose to sugar moieties of glycolipids and glycoproteins by a-1,2-fucosylation. Various isoforms of fucosyltransferase have been implicated in vascular formation.
(5-7) Data on the role of FUT2 in angiogenesis are scarce. However, formation of an intact glycocalyx is particularly important in vascular endothelial cells, and lack of Fut2 activity may alter vascular anatomy. Correspondingly, recent studies have suggested a role for FUT2 in this process. (8) FUT2 also plays an important role in the formation of ABH blood group antigens present on epithelial cell membranes and in biological fluids. About 20% of the population is homozygous for enzyme-inactivating variants of FUT2. These individuals are unable to secrete ABH blood group antigens in their fluids and are therefore called "nonsecretors." (9) As for many risk genes identified by GWAS in different diseases, a genetic association does not necessarily imply a causal relationship of a genetic variant with disease development. Regarding FUT2, however, a potential role in hepatobiliary and intestinal physiology appears likely. FUT2 variants have been associated with elevated serum markers of cholestasis. (10) FUT2 variants also have profound effects on the gut microbiota composition in mice (11) and humans and have been associated with the development of Crohn's disease. (12) (13) (14) Rapid a-1,2-fucosylation has been identified as a protective mechanism in intestinal epithelial cells that uses the host's resources to maintain hostmicrobial interactions during pathogen-induced stress and, thereby, sustains host-commensal symbiosis. (15) FUT2 also contributes to the formation of the biliary glycocalyx by a-1,2-fucosylation of cholangiocyte membrane glycoproteins. (16) a-1,2-Fucosylated glycans are not present on the apical surface of the biliary epithelium of nonsecretor individuals. Among PSC patients, nonsecretors have a different composition of bile microbiota and increased risk of biliary candida infections and dominant stenosis compared to secretors. (17) We previously demonstrated that an intact biliary glycocalyx is essential to stabilize the "biliary HCO 3 -umbrella," (18) to maintain an alkalized milieu on the cholangiocellular surface, and to protect cholangiocytes against pH-dependent cell injury by hydrophobic bile acids. (16, 19) The capacity of cholangiocytes to alkalinize the pericellular milieu greatly determines their resistance toward bile acid-induced damage. (18, 19) Therefore, in the present study, we investigated the biliary and vascular phenotype of Fut2 -/-mice and the contribution of Fut2 in the development of hepatobiliary damage in mice exposed to human hydrophobic bile acids.
Materials and Methods

ANIMALS
Fut2
-/-mice were obtained from The Jackson Laboratory (Bar Harbor, ME) and subsequently bred inhouse in the animal facility of the Academic Medical
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Center, Amsterdam, The Netherlands. Wild-type (wt) mice were purchased from Harlan (Horst, The Netherlands). All mice were on a C57BL/6J background. Animals were kept in a pathogen-free environment under controlled conditions (12-hour light/dark cycle, 22 8C). A standard chow diet and water were available ad libitum before the experiments.
For bile salt feeding experiments, male mice of 6 weeks of age were first fed a purified semisynthetic diet for 2 weeks (K4068.02; Arie Blok Diervoeders, Woerden, The Netherlands), followed by the administration for an additional 2 weeks of purified semisynthetic diet (control), either supplemented with 0.3% glycochenodeoxycholate (GCDC; Sigma-Aldrich, St. Louis, MO) or not. Fut2 -/-mice with low serum bile salt levels (Fut2 -/-low ) and Fut2 -/-mice with high serum bile salt levels (Fut2 -/-high ; see Results for further information) were housed together during feeding experiments in order to minimize microbiome differences. All animal experiments were approved by the Institutional Animal Care and Use Committee of the Academic Medical Center.
LIVER HISTOLOGY
Livers were fixed in 4% paraformaldehyde solution and embedded in paraffin wax. Sections (7 lm) were stained with hematoxylin and eosin, sirius red, elasticavan Gieson, and periodic acid-Schiff-diastase. Immunohistochemistry for cytokeratin (Ck)-19 was performed on formalin-fixed, paraffin-embedded liver sections as follows. After dewaxing and rehydration, unspecific protein binding was blocked with Ultra-Vblock (Lab Vision; Thermo Fisher Science, Fremont, CA) for 30 minutes at room temperature. Liver sections were then incubated with or without a Ck-19 primary antibody (Eurogentec; 1:1,000 in phosphatebuffered saline 0.1% Triton-X100). After exposure to alkaline phosphatase-conjugated secondary antibody for 2 hours at room temperature, reactive sites were detected using the Vector Blue Alkaline Phosphatase Substrate Kit (Vector Laboratories).
In liver specimens of wt, Fut2 
QUANTITATIVE PCR ANALYSIS OF GENE EXPRESSION
Liver tissue was snap-frozen and stored at -808C. RNA was isolated from tissue using Trizol reagent (Invitrogen, Leiden, The Netherlands). Complementary DNA synthesis was obtained using deoxythymidine oligomer and random hexamer primers and Superscript III reverse transcriptase (Invitrogen). Quantitative PCR was performed using a Lightcycler 2.0 with the Fast Start DNA Master Plus SYBR Green I kit (Roche, Woerden, The Netherlands). Housekeeping genes were selected using the geNorm algorithm. (20) 
BILE COLLECTION AND SERUM BIOCHEMISTRY
To obtain bile, mice were anesthetized and placed on a warm heating pad to maintain body temperature stable. After laparotomy and ligation of the common bile duct, the gallbladder was cannulated and bile flow was quantified gravimetrically in preweighed tubes. Bile was collected in fractions of 10 or 15 minutes. Serum liver tests were analyzed by the routine laboratory of clinical chemistry of the Academic Medical Center. Plasma bile salt composition, bilirubin species, and fecal bile salt concentrations were determined by reverse-phase high-performance liquid chromatography (HPLC). In brief, 100 lL of diluted bile, plasma, or fecal samples were applied to a Hypersil C18 (3 lm, 15 cm) HPLC column (Thermo Scientific, Breda, The Netherlands). The starting eluent consisted of 6.8 mmol/L of ammonium formate (pH 3.9), followed by a linearly increasing gradient of acetonitrile (Biosolve, Valkenswaard, The Netherlands). Detection was performed using a nano-quantity analyte detector (based on condensation nucleation) (QT-500; Quant Technologies, Blaine, MN). Concentrations for different bile salt species were determined by calibration curves for each species upon HPLC.
For ammonia measurements, 20 lL of whole blood collected from the inferior vena cava were incubated for 3 minutes on ammonia test strips (Ammonia Test Kit II; Arkray Inc., Japan) and then measured with a blood ammonia meter (Ammonia Checker II; Daiichi Kagaku Co., Ltd., Japan).
PORTAL ANGIOGRAPHY
Wt, Fut2 -/-low , and Fut2 -/-high mice were anesthetized with isoflurane. After a ventral abdominal incision, the mesentery was turned over to the left side of the abdomen in order to best expose the portal vein. A 0.8-mm catheter was then inserted into the portal vein and secured with two 6-0 silk ties. A total of 0.2 mL of contrast agent (Visipaque 320; GE Healthcare, Waukesha, WI; diluted 1:1 in saline solution) was manually injected in the portal circulation through the catheter. Images were continuously acquired by a Mobile C-Arm 9800 OEC (GE Healthcare, Salt Lake City, UT).
STATISTICAL ANALYSIS
All data are presented as mean 6 standard deviation (SD). Significance was tested by use of two-way analysis of variance (ANOVA) with Bonferroni's correction for multiple testing. Differences were considered to be statistically significant when P < 0.05.
Results
Fut2 -/-MICE ARE VIABLE AND FERTILE
Female Fut2 -/-mice were able to bear normal pregnancies as described. (21) Although the size of nests appeared to be comparable to those of wt mice, (21) 
Fut2
-/-mice tended to lose pups soon after birth. We observed maternal infanticide behavior and estimated that about 40% of the litter died and/or were eaten by the mother within 12 hours after birth for unknown reasons, although it cannot be ruled out that Fut2 -/-mothers ate severely ill or stillborn pups only. (22) After this time point, we did not register unusual dropout. Growth curves of Fut2 -/-pups that survived were comparable to those of wt animals (Fig. 1A) . Fut2 -/-adult mice displayed gray fur but no other evident morphological alterations and had normal behavior.
-/-MICE SHOW ELEVATED SYSTEMIC BILE SALT LEVELS (Fig. 1B) . This phenotype was stable, and both groups maintained their respective bile salt levels over time, as determined at 6 and 12 weeks of age (data not shown). The subgroups did not differ in weight, growth, gross development, and sex ratio (Fut2 -/-high , n 5 18, 10 male, 8 female; Fut2 -/-low , n 5 26, 14 male, 12 female). In Fut2 -/-high mice, the increased plasma bile salt levels were mainly caused by taurine conjugates of cholate (taurocholate) and b-tauromuricholate and to a minor extent by those of tauroursodeoxycholate and atauromuricholate (Fig. 1C) . In all subgroups, taurochenodeoxycholate and taurodeoxycholate constituted <2% of total bile salt species. Unconjugated ursodeoxycholate, deoxycholate, and chenodeoxycholate were not detected, just as glycine-conjugated bile salts.
Fut2 -/-MICE SHOW NORMAL BILE FLOW, NORMAL BILE SALT SECRETION, AND NORMAL EXPRESSION OF KEY BILE SALT TRANSPORTERS AND OF CYTOCHROME P450 7A1 INDEPENDENTLY OF SERUM BILE SALT LEVELS
In light of the increased peripheral bile salt levels in Fut2 -/-high animals, possible impairments of bile production and bile salt secretion capacity were tested. To this end, bile flow and bile salt secretion into bile were determined over 60 minutes. Fut2 -/-high mice tended to have a lower bile flow at 10 and 30 minutes (Fig.  1D) . However, the same mice showed a similar bile salt output in bile compared to wt and Fut2 -/-low mice (Supporting Fig. S1A ). The bile salt output was increased only in Fut2 -/-low mice at 10 minutes. To check for a possible increase in bile salt synthesis in Fut2 -/-mice, we also studied the excretion of bile salts in feces. The amount of bile salts excreted did not differ between the three groups (Supporting Fig. S1B) .
In order to further investigate hepatic bile salt homeostasis on a molecular level, mRNA expression of the key hepatic bile salt transporters and of the rate-limiting enzyme of bile salt synthesis, cytochrome P450 7a1 (Cyp7a1), was determined. mRNA levels of Bsep, Mrp3, Ntcp, and Oatp1b2 in whole-liver lysates were
-/-mice display normal growth pattern and increased serum bile salt levels. (A) Growth curves of Fut2 -/-mice measured from birth to 60 days of age were comparable to wt animals (mean 6 SD, n 5 15 for both groups). (B) Total fasted serum bile salts were higher in Fut2 -/-mice compared to wt mice. Notably, about half of all Fut2 -/-mice presented with normal bile salt levels (Fut2 -/-low ) and half of Fut2 -/-mice with markedly elevated bile salt levels (Fut2 -/-high ) (*P < 0.05 versus wt, Student t test). (C) HPLC analysis of serum bile salt composition revealed that the increased bile salt levels in Fut2 -/-high mice were mainly caused by taurine conjugates of cholate (taurocholate) and btauromuricholate and to a minor extent by taurine conjugates of tauroursodeoxycholate and a-tauromuricholate (mean 6 SD, n 5 3-6 for each group comparable between the three groups (Fig. 1E) . Notably, despite the substantial increase in bile salt concentration in plasma of Fut2 -/-high mice, the expression level of Cyp7a1 was also not different between the three groups (Fig. 1E) .
Thus, bile formation and bile salt secretion were not altered in Fut2 -/-high mice when compared to Fut2 -/-low mice and wt controls.
Fut2 -/-high MICE ARE SENSITIVE TO BILE SALT-INDUCED HEPATOBILIARY DAMAGE
We hypothesized that Fut2 may contribute to the stabilization of the biliary HCO 3 -umbrella and thus to the resistance of cholangiocytes toward bile acidinduced damage. (18, 23) To test this hypothesis, Fut2
-/-mice were challenged with a diet supplemented with 0.3% GCDC. While wt mice and Fut2 -/-low mice were unaffected by GCDC feeding, Fut2 -/-high mice showed a dramatic weight loss already after 6 days, developed acute liver damage, and were sacrificed after 2 weeks of GCDC feeding due to severe illness according to the protocol of the animal facility ( Fig. 2A) . In these Fut2 -/-high mice serum levels of alkaline phosphatase (Fig. 2B) , AST (Fig. 2C) , and ALT (Fig. 2D) were increased. Histopathology showed areas of parenchymal necrosis in Fut2 -/-high mice but not Fut2 -/-low mice or wt mice (Supporting Fig. S2 ). Thus, Fut2 -/-high mice are sensitive to bile salt-induced hepatobiliary damage.
Fut2 -/-high MICE SHOW ALTERATIONS OF LIVER HISTOMORPHOLOGY
Upon histological examination of 18 male Fut2 -/-mice at an age of 8 weeks, 56% of the livers appeared
FIG. 2. Fut2
-/-high mice are susceptible to GCDC-induced hepatobiliary damage. In Fut2 -/-high mice (black line), but not in Fut2 -/-low mice (gray line) and wt mice (gray dashed line), administration of a 0.3% GCDC-supplemented diet caused (A) a rapid and dramatic body weight loss to as much as 22% of the initial body weight after 6 days of GCDC administration and increased serum activity of (B) alkaline phosphatase, (C) AST, and (D) ALT (mean 6 SD; *P < 0.05, ANOVA with Bonferroni correction). Wt, Fut2 -/-low , and Fut2 -/-high mice are depicted by white, gray and black bars, respectively. Abbreviations: ALP, alkaline phosphatase; CT, control.
comparable to those of wt mice, whereas 44% showed a clearly aberrant morphology of the portal tracts (Fig.  3A) . Strikingly, the alterations only affected Fut2 -/-high mice and mainly involved the larger portal triads. The main histomorphological alterations occurred in and around the portal tracts, including microcirculatory disturbances, the presence of paraportal shunting vessels, increased numbers of portal vascular structures, wall thickening of some portal arteries, and occurrence of periductal fibrosis (Fig. 3C,D) . Centrilobular veins and pericentral zone 3 appeared normal in all mice (not shown). Ck-19 staining revealed no clear evidence of cholangiocyte proliferation or ductular reaction in the livers of Fut2 -/-mice, irrespective of the bile salt levels (high/ low) and of the histomorphological alterations in the portal triads as described above (Fig. 3B) .
Sirius red staining disclosed an accumulation of collagen fibrils around bile ductules and blood vessels in the aberrant portal triads of Fut2 -/-high mice but not in wt and Fut2 -/-low mice (Fig. 3C ). Well-delineated fibrotic septa (e.g., portoportal septa) were not detected in the liver parenchyma of the three groups of 8-weekold mice.
Thus, histomorphological analysis disclosed (peri)-portal microcirculatory disturbances consistent with portosystemic shunting in Fut2 -/-high mice.
Fut2 -/-high MICE HAVE EXTENSIVE PORTOSYSTEMIC SHUNTS
Given the markedly increased levels of conjugated bile salts in peripheral plasma in the absence of impaired bile secretion or molecular alterations in bile salt homeostasis, we postulated the presence of portosystemic shunts in Fut2 -/-high mice. In support of this hypothesis, the serum levels of unconjugated bilirubin were significantly increased in Fut2 -/-high mice (Fig.  4A) . Also ammonia levels measured at the level of the vena cava inferior tended to be higher in Fut2 -/-high mice than Fut2 -/-low or wt mice (Fig. 4B) . In order to test this hypothesis, we performed portal angiographies in wt, Fut2 -/-low , and Fut2 -/-high mice. In wt animals with a normal anatomy, the contrast agent injected through the portal vein rapidly filled the portal branches and after 2.5 seconds had reached the right atrium (Fig. 5A) , followed by enhancement of the pulmonary vessels. In Fut2 -/-low mice, enhancement of the portal vessels was weaker than in wt mice, while the right atrium and pulmonary vessels showed an earlier enhancement, suggesting partial portosystemic shunting (Fig. 5B) . This effect was much more pronounced in Fut2 -/-high animals, where no portal filling was initially seen at all but rapid enhancement of the right atrium and the pulmonary system was found, indicating a near-complete portosystemic shunt (Fig.  5C ) (also see representative videos in Supporting Information). A faint enhancement of the liver parenchyma appeared only later, when the contrast reached the liver putatively through the hepatic artery.
Thus, in line with the biochemical serum alterations discussed above, portosystemic shunting was confirmed angiographically, with nearly complete portosystemic shunting in Fut2 -/-high animals.
Discussion
In the present study, we show that about 50% of mice lacking the PSC risk gene Fut2 show features of extensive congenital portosystemic shunts. Extensive shunting was associated with markedly elevated serum levels of bile salts (Fut2 -/-high mice) and unconjugated bilirubin and (peri)portal microcirculatory disturbances at histological examination with mild, likely secondary, periductal fibrosis. These Fut2 -/-high mice, but neither wt littermates nor Fut2 -/-low mice, were highly sensitive to hepatobiliary damage when challenged with the major human hydrophobic bile salt GCDC.
The pathogenesis of PSC remains elusive. (1, 24, 25) Complex and still not completely defined interactions between genetic predisposition and environmental factors are thought to influence disease development and progression. (24) In recent years, GWAS have advanced our understanding of the heritability of PSC, and the list of risk genes is rapidly expanding. (3, 4, 26, 27) Together with inactivating single-nucleotide polymorphisms in FUT2, between 30 and 40 nominally significant associations at other genetic loci have been identified in PSC. (4, 28) The pathophysiological implications of these associations, however, have not been demonstrated to date, and further efforts are needed to elucidate the biology of single genes and of gene-environment interactions in the context of normal and diseased liver. (28) We present experimental evidence that inactivation of Fut2 affects liver physiology and anatomy. Despite the limitations of the rodent context, knockout of Fut2 in mice corresponds to the human homozygous situation with complete FUT2 inactivation present in about 20% of the population. (9, 29) Among others, blood group antigens and host-microbe -/-high mice (but not wt mice and Fut2 -/-low mice), bile ducts (*) with accompanying arterial branches (1) with prominent thickening of arterial wall (horizontal line, indicating arterial wall thickness) were seen. (E) Thickening of the walls of larger bile ductules due to periductular fibrosis and (F) periductular infiltration of immune cells were scored independently in a blinded fashion by three experienced investigators. Analysis revealed that periductal fibrosis, but not inflammatory infiltrate, was markedly more pronounced in Fut2 -/-high mice (n 5 9) than wt mice (n 5 10) and Fut2 -/-low mice (n 5 9). Wt, Fut2 -/-low , and Fut2 -/-high mice are depicted by white, gray and black bars, respectively (different from wt, *P < 0.05).
interactions are profoundly influenced by this nonsecretor status. (14, 30) Serum biochemistry of Fut2 -/-mice revealed two subgroups of comparable size with either normal or markedly elevated concentrations of peripheral bile salts (Fut2 -/-low versus Fut2 -/-high mice). The elevated levels of bile salts were mainly caused by taurine conjugates of muricholate and cholate (Fig. 1C) , resulting in a systemic bile salt composition comparable with murine portal blood. (31) In plasma samples of wt and Fut2 -/-low mice, but not in Fut2 -/-high mice, low concentrations of deoxycholate were detected. The possibility of cholestasis in Fut2 -/-high mice was investigated as an explanation for elevated plasma bile salt concentrations and virtual lack of serum deoxycholate, but all experimental lines of evidence argued against cholestasis: (1) serum levels of alkaline phosphatase, AST, and ALT were normal in Fut2 -/-high mice on standard chow (Fig. 2B-D) ; (2) Fut2 -/-high mice tended to have a lower bile flow compared to wt mice (Fig. 1D) , but biliary bile salt output was unaltered (Fig. 1E) ; (3) the amount of bile salts excreted with feces was comparable among the groups (Fig.  1F) , thus indicating that endogenous synthesis of bile salts was not altered in Fut2 -/-high mice (32) ; (4) hepatic mRNA levels of Ntcp, Bsep, Oatp1b2, and Mrp3 (Fig. 1G) , the main hepatic transporters involved in the enterohepatic circulation of bile salts, (33) were unaltered in Fut2 -/-high mice; (5) expression of Cyp7a1, the rate-limiting and tightly regulated enzyme in the synthesis of bile salts, (33) was not down-regulated in Fut2 -/-high mice, as had been expected on the basis of -/-high mice compared to wt and Fut2 -/-low mice (mean 6 SD, n 5 4-8 for each group; *P < 0.05, ANOVA with Bonferroni correction). (B) Ammonia levels measured at the level of the inferior vena cava tended to be higher in Fut2 -/-high mice compared to wt and Fut2 -/-low mice (mean 6 SD, n 5 3 for each group). (C) Spleen to body weight ratio was higher in Fut2 -/-high mice, whereas (D) liver to body weight ratio was lower in Fut2 -/-high mice compared to wt mice (mean 6 SD, n 5 7-12 for each group (different from wt, *P < 0.05, ANOVA with Bonferroni correction). Abbreviations: BMG, bilirubin monoglucuronide; UCB, unconjugated bilirubin. markedly elevated serum bile salt levels (Fig. 1G) . Thus, cholestasis did not explain hypercholanemia in Fut2 -/-high mice. On histomorphological analysis of liver tissue, the main alterations occurred in and around the portal tracts with microcirculatory disturbances, including the presence of paraportal shunting vessels, increased number of portal vascular structures and wall thickening of some hepatic artery branches (Fig. 3D) , and occurrence of (mild) periductal fibrosis. No clear thickening of the basal membrane around bile ducts was seen (periodic acid-Schiff-diastase/elastica-van Gieson stain). The abnormalities mainly involved medium to large portal tracts, while the centrilobular veins and pericentral zone 3 were unaffected. Ck-19 and sirius red stainings excluded the presence of cholangiocyte proliferation and hepatic fibrosis, respectively, at the age of 8 weeks (Fig. 3B,C) .
Arterial wall thickening with fibrointimal hyperplasia has been described as a feature of PSC. (34, 35) Its pathogenetic contribution remains unknown, but it has been speculated that this is a consequence of increased arterial flow in PSC patients. In our animals, portal blood flow through the liver can be expected to be decreased due to portosystemic shunting. Through the hepatic arterial buffer response, changes in portal venous inflow may lead to a compensatory increase in hepatic arterial flow and/or pressure. This sequence of events is mimicked in secondary sclerosing cholangitis, where mechanical ventilation-associated positive endexpiratory pressure and hepatic arterial buffer response may also result in an increased hepatic arterial blood flow. (35) Bile duct sclerosis/sclerosing cholangitis is a hallmark of PSC but has also been observed in other conditions such as ABCB4 deficiency in humans, a defect of the phospholipid floppase multidrug resistance 3 (MDR3), which mediates biliary phosphatidylcholine secretion. (36, 37) Phosphatidylcholine forms mixed micelles with bile salts and cholesterol in bile, thereby lowering bile salt toxicity and concentrations of bile salt monomers. In analogy, fibrosis of bile ductules as observed in our Fut2 -/-high mice (Fig. 3A) has been described in, among others, Mdr2 -/-mice, an equivalent of human ABCB4 deficiency. (38) Sclerosing cholangitis in Mdr2 -/-mice has been attributed to "toxic bile": Mdr2 -/-mice lack cholangiocyte protection by biliary phospholipids against hydrophobic bile salt monomers. (38) Our finding of periductal fibrosis of bile ductules in Fut2 -/-high mice cannot be explained by changes in biliary bile salt secretion, which remained stable (Fig. 1E) , although inflow of bile salts from the systemic circulation was 40 times elevated in Fut2 -/-high mice. Thus, periductal fibrosis most likely represents a consequence of portosystemic shunting in Fut2 -/-high mice. In order to study the potential role of Fut2 in biliary protection against toxic bile acids, we challenged Fut2 -/-mice with a GCDC-enriched diet. GCDC is the most prominent potentially toxic bile salt accumulating in human cholestatic diseases. (39) We have shown that GCDC feeding yields significant biliary GCDC levels despite the pronounced rehydroxylation capacity in mice. (40) Fut2 -/-animals had a dichotomic reaction to the bile salt feeding. While Fut2 -/-low mice showed trends comparable to wt mice in terms of body weight and serum liver tests, Fut2 -/-high mice became severely ill and developed weight loss and acute liver disease ( Fig. 2A-E) . Histological assessment revealed areas of hepatocellular necrosis in Fut2 -/-high animals on hematoxylin and eosin staining but not in wt mice and Fut2 -/-low mice (Supporting Fig. S2 ). In light of the biochemical and histological alterations described above, we hypothesized the presence of portosystemic shunting in Fut2 -/-high mice. In line with this hypothesis, unconjugated bilirubin was increased and the ammonia levels tended to be higher in Fut2 -/-high mice (Fig. 4A,B) . Portal angiography showed the presence of a large communication between the portal vein and the vena cava in Fut2 -/-high mice, identifying a near-complete portosystemic shunt (Fig. 5) . The contrast injected completely shunted the liver and filled the right side of the heart. A faint hepatic enhancement appeared only later -/-low , and Fut2 -/-high mice. In wt mice the contrast agent injected through the portal vein rapidly filled the portal branches (1.5 seconds), with gradual enhancement of the liver parenchyma (2.5 seconds), until reaching the right atrium (4.8 seconds). In Fut2 -/-low mice, portal branches showed a weak enhancement following injection of the contrast agent (0.5 seconds), which reached the right atrium (1.5 seconds) before complete enhancement of the liver parenchyma (4.5 seconds), suggesting the presence of partial portosystemic shunting. In Fut2 -/-high mice, the contrast agent injected through the portal vein entirely bypassed the liver parenchyma and reached the right atrium (1.5 seconds) through a complete portosystemic shunt. Arrowhead indicates shunt.
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HEPATOLOGY, August 2017 through the arterial route, when the contrast agent had reached the aorta of the mice. In Fut2 -/-low mice, a delayed enhancement of the portal vessels suggested the presence of an incomplete portosystemic shunt. The prominent shunt of Fut2 -/-high mice might explain the spontaneous alterations in liver histology and serum biochemistry of these mice. Of note, histological abnormalities comparable to those reported in Fut2 -/-high mice have been described in case of portosystemic shunts. (41, 42) Portosystemic shunts have been reported to be sporadically present in the genetic background of our mice, C57BL/6J. (43) We can only speculate on the cause of the increased frequency of portosystemic shunting in Fut2 -/-mice. Notably, the frequency of this phenomenon, associated with and indicated by high bile salt levels, did not change with selective breeding of couples formed by either Fut2 -/-low or Fut2 -/-high mice. Independently of the phenotype of the parental generation, offspring developed the phenotype at comparable rates (data not shown). This suggests a limited penetrance of the phenotype, which may be related to developmental effects of the mutation.
Sensitivity of Fut2 -/-high mice to bile salt-induced hepatobiliary damage may partly be linked to portosystemic shunting per se. Portocaval shunts induce patchy hepatic necrosis in the setting of bile duct ligation, (44) matching the parenchymal necrosis we observed in our animals (Supporting Fig. S2 ). However, liver damage and patchy necrosis were only found in Fut2 -/-animals when the diet was supplemented with 0.3% GCDC. Animals on the control diet or the 0.1% GCDC diet (latter not shown) were unaffected, despite the portosystemic shunting. Thus, shifting the bile salt composition toward a human, hydrophobic bile salt pool and hepatic accumulation of bile salts in these animals is likely to have induced the liver phenotype of our animals on the basis of the vascular malformation.
As for other genes identified by GWAS, the data obtained in animal models have to be interpreted with particular care. To this extent, knockout mouse models deliberately simplify the interactions between different genes and between genes and environment in order to dissect the specific role of a protein. The effect size of a gene might be reshaped or overshadowed in humans due to such complex interplays. Nonetheless, the results of this study open novel intriguing possibilities that deserve further studies. The occurrence of PSC might be more frequent in nonsecretor individuals, which lack a functional FUT2 protein. Moreover, subclinical shunts in nonsecretors may not only play a role in the development of PSC but also influence the appearance of complications of liver cirrhosis related to portosystemic shunting, such as hepatic encephalopathy.
In conclusion, we show that mice lacking expression of the PSC risk gene Fut2 can develop a nearcomplete portosystemic shunt associated with increased levels of serum bile salts; abnormalities in liver histology, including signs of portosystemic shunting, resulting in microcirculatory disturbances and mild (secondary) periductal fibrosis; and increased sensitivity to bile salt-induced hepatotoxicity.
